Google’s AI Reshuffle Is a TPU War
The Hassabis shift and the Dean exit are symptoms. The chip allocation fight is the disease.
The Hassabis shift and the Dean exit are symptoms. The chip allocation fight is the disease.
A record Q2 beat rate has raised the bar so high that even a strong H2 may disappoint.
Six straight quarters of U.S. sales declines, a halved dividend, withdrawn guidance, and a new CEO who told Wall Street…
A White House removal letter and a hawkish rate warning landed the same week. The market shrugged. It probably shouldn't.
The real question isn’t whether Berkshire’s new CEO is deploying capital. It’s whether he’s deploying it well enough, at the…
Nielsen’s $2.15 billion deal would close the book on public ad verification. Here is what the trade, the shift, and…
A $30B revenue run-rate, Samsung 2nm talks, and a job listing up to $485K just redrew the custom silicon map.
August 10, 2026 Barrick Beat on Ounces. Costs Won the Quarter. Production beat guidance. Costs...
UBS mapped three conditions for gold’s next leg. Friday’s payrolls report just satisfied the most important one.
Ooredoo just committed $800M to Indonesia and Mubadala is weighing $6.3B in Japan. The Asia pivot is no longer a…